This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
Gabapentin Tablets are indicated for management of postherpetic neuralgia in adults
India has a pivotal role in eliminating TB
hubergroup’s two newly added medical vans are dedicated to dental and eye care
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
Women of all ages will get round-the-clock access to comprehensive treatment
FedEx will be displaying a wide-range of effective healthcare packaging and specialized tracking technology
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The observations are procedural in nature
Subscribe To Our Newsletter & Stay Updated
